These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 23594286)
1. Utility of intrathoracic impedance monitoring in pediatric and congenital heart disease. LaPage MJ; von Alvensleben J; Dick M; Serwer G; Bradley DJ Pacing Clin Electrophysiol; 2013 Aug; 36(8):994-9. PubMed ID: 23594286 [TBL] [Abstract][Full Text] [Related]
2. Assessment of intrathoracic impedance algorithm in the pediatric and adult congenital population. Silva JN; VON Bergen NH; Dubin AM; Collins KK; Chen J; Bowman TM; Van Hare GF Pacing Clin Electrophysiol; 2014 Sep; 37(9):1174-80. PubMed ID: 24646399 [TBL] [Abstract][Full Text] [Related]
3. Sensitivity and positive predictive value of implantable intrathoracic impedance monitoring as a predictor of heart failure hospitalizations: the SENSE-HF trial. Conraads VM; Tavazzi L; Santini M; Oliva F; Gerritse B; Yu CM; Cowie MR Eur Heart J; 2011 Sep; 32(18):2266-73. PubMed ID: 21362703 [TBL] [Abstract][Full Text] [Related]
4. Fundamentals of intrathoracic impedance monitoring in heart failure. Wang L Am J Cardiol; 2007 May; 99(10A):3G-10G. PubMed ID: 17512421 [TBL] [Abstract][Full Text] [Related]
5. Refined heart failure detection algorithm for improved clinical reliability of OptiVol alerts in CRT-D recipients. Vamos M; Nyolczas N; Bari Z; Bogyi P; Muk B; Szabo B; Ancsin B; Kiss RG; Duray GZ Cardiol J; 2018; 25(2):236-244. PubMed ID: 28653309 [TBL] [Abstract][Full Text] [Related]
6. Decreased Intrathoracic Impedance Associated With OptiVol Alert Can Diagnose Increased B-Type Natriuretic Peptide - MOMOTARO (Monitoring and Management of OptiVol Alert to Reduce Heart Failure Hospitalization) Study - . Nishii N; Kubo M; Okamoto Y; Fujii S; Watanabe A; Toyama Y; Yamada T; Doi M; Morita H; Ito H; Circ J; 2015; 79(6):1315-22. PubMed ID: 25787230 [TBL] [Abstract][Full Text] [Related]
7. Improved algorithm to detect fluid accumulation via intrathoracic impedance monitoring in heart failure patients with implantable devices. Sarkar S; Hettrick DA; Koehler J; Rogers T; Grinberg Y; Yu CM; Abraham WT; Small R; Tang WH J Card Fail; 2011 Jul; 17(7):569-76. PubMed ID: 21703529 [TBL] [Abstract][Full Text] [Related]
8. Persistently abnormal device-detected thoracic impedance and OptiVol fluid index related to breast reconstruction surgery. Nagra B; Ibrahim T; Shah AN; Kantharia BK Pacing Clin Electrophysiol; 2023 Apr; 46(4):323-326. PubMed ID: 36272170 [TBL] [Abstract][Full Text] [Related]
9. Intrathoracic impedance monitoring to predict decompensated heart failure. Ypenburg C; Bax JJ; van der Wall EE; Schalij MJ; van Erven L Am J Cardiol; 2007 Feb; 99(4):554-7. PubMed ID: 17293202 [TBL] [Abstract][Full Text] [Related]
10. Changes in intrathoracic impedance are associated with subsequent risk of hospitalizations for acute decompensated heart failure: clinical utility of implanted device monitoring without a patient alert. Small RS; Wickemeyer W; Germany R; Hoppe B; Andrulli J; Brady PA; Labeau M; Koehler J; Sarkar S; Hettrick DA; Tang WH J Card Fail; 2009 Aug; 15(6):475-81. PubMed ID: 19643357 [TBL] [Abstract][Full Text] [Related]
11. Device monitoring of intrathoracic impedance: clinical observations from a patient registry. Andriulli J Am J Cardiol; 2007 May; 99(10A):23G-8G. PubMed ID: 17512419 [TBL] [Abstract][Full Text] [Related]
12. Rationale and design of a prospective trial to assess the sensitivity and positive predictive value of implantable intrathoracic impedance monitoring in the prediction of heart failure hospitalizations: the SENSE-HF study. Cowie MR; Conraads V; Tavazzi L; Yu CM; J Card Fail; 2009 Jun; 15(5):394-400. PubMed ID: 19477399 [TBL] [Abstract][Full Text] [Related]
13. Impact of Remote Monitoring on Hospitalizations for Heart Failure: A Five-year Single-center Experience. Rosman J; Rosenbaum M; Berkowitz E; Kloosterman EM J Innov Card Rhythm Manag; 2021 Aug; 12(8):4621-4624. PubMed ID: 34476114 [TBL] [Abstract][Full Text] [Related]
14. Integrating device-based monitoring into clinical practice: insights from a large heart failure clinic. Small RS Am J Cardiol; 2007 May; 99(10A):17G-22G. PubMed ID: 17512418 [TBL] [Abstract][Full Text] [Related]
15. An improved algorithm calculated from intrathoracic impedance can precisely diagnose preclinical heart failure events: Sub-analysis of a multicenter MOMOTARO (Monitoring and Management of OptiVol Alert to Reduce Heart Failure Hospitalization) trial study. Miyoshi A; Nishii N; Kubo M; Okamoto Y; Fujii S; Watanabe A; Okawa K; Kawamoto K; Morita H; Ito H J Cardiol; 2017 Nov; 70(5):425-431. PubMed ID: 28673507 [TBL] [Abstract][Full Text] [Related]
16. Randomized Clinical evaluatiON of wireless fluid monitoriNg and rEmote ICD managemenT using OptiVol alert-based predefined management to reduce cardiac decompensation and health care utilization: the CONNECT-OptiVol study. Zabel M; Vollmann D; Lüthje L; Seegers J; Sohns C; Zenker D; Hasenfuss G Contemp Clin Trials; 2013 Jan; 34(1):109-16. PubMed ID: 23073567 [TBL] [Abstract][Full Text] [Related]
17. Intrathoracic impedance monitoring, audible patient alerts, and outcome in patients with heart failure. van Veldhuisen DJ; Braunschweig F; Conraads V; Ford I; Cowie MR; Jondeau G; Kautzner J; Aguilera RM; Lunati M; Yu CM; Gerritse B; Borggrefe M; Circulation; 2011 Oct; 124(16):1719-26. PubMed ID: 21931078 [TBL] [Abstract][Full Text] [Related]